PP09 Presentation Time: 11:20 AM: High-Dose-Rate Brachytherapy Boost Combined with Ultra-Hypofractionated Radiation for Unfavorable Intermediate and High Risk Prostate Cancer

Daniel Gorovets,Margaret Hopkins,Assaf Moore,Arrun Goel,Marisa Kollmeier,Daniel Shasha,Victoria Brennan,Sean Mcbride,Gilad Cohen,Antonio Damato,Michael J Zelefsky

doi:10.1016/j.brachy.2021.06.010

PP09 Presentation Time: 11:20 AM: High-Dose-Rate Brachytherapy Boost Combined with Ultra-Hypofractionated Radiation for Unfavorable Intermediate and High Risk Prostate Cancer

Daniel Gorovets, Margaret Hopkins + Show 9 more

https://doi.org/10.1016/j.brachy.2021.06.010

Copy DOI

Journal: Brachytherapy

Publication Date: May 1, 2021

Affiliation: Memorial Sloan Kettering Cancer Center

#Five-fraction Stereotactic Body Radiation Therapy #High Risk Prostate Cancer + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Purpose: This study aimed to evaluate outcomes associated with a single-fraction high-dose-rate (HDR) brachytherapy boost combined with five-fraction stereotactic body radiation therapy (SBRT) for patients with unfavorable intermediate- or high-risk prostate cancer.

Full Text